De Jesus Orlando
Department of Surgery, Section of Neurosurgery, University of Puerto Rico, San Juan, Puerto Rico, United States.
Surg Neurol Int. 2023 Jun 16;14:206. doi: 10.25259/SNI_418_2023. eCollection 2023.
Demographics and socioeconomic variables for patients with pituitary adenomas have been reported in the past. However, these studies included operated and nonoperated patients, in addition to microprolactinomas frequently diagnosed in women, revealing an elevated incidence among females. This study aimed to analyze the surgical incidence of pituitary adenomas for an adult Hispanic population in Puerto Rico over 6 years.
A retrospective and descriptive study was performed to investigate pituitary adenoma surgical incidence (per 100,000 people) among surgically treated pituitary adenomas in an adult (18 years or more) Puerto Rico Hispanic population. All new patients diagnosed with pituitary adenomas who underwent surgery at the Puerto Rico Medical Center between 2017 and 2022 were scrutinized. Inclusion criteria required a histopathological diagnosis of pituitary adenoma. Previously operated cases and non-Hispanic patients were excluded from the study. Patient characteristics were collected, along with the type of surgical treatment, tumor size, and secretory status.
The analysis included 143 patients operated on for pituitary adenomas. Of these, 75 (52%) patients were male, and 68 (48%) were female. The median age of the patients was 56 years (range: 18-85). The average annual surgical incidence of adult Hispanic patients with pituitary adenomas was 0.73 surgeries/100,000 people. About 79% of the patients had non-functioning pituitary adenomas. About 94% of the patients were operated on using transsphenoidal surgery.
There was no sex predominance for surgical-treated pituitary adenomas in Puerto Rico. The surgical incidence for adult pituitary adenoma remained stable between 2017 and 2022.
过去已有关于垂体腺瘤患者的人口统计学和社会经济变量的报道。然而,这些研究包括接受手术和未接受手术的患者,此外还经常诊断出女性患有微泌乳素瘤,显示女性发病率较高。本研究旨在分析波多黎各成年西班牙裔人群6年来垂体腺瘤的手术发病率。
进行了一项回顾性描述性研究,以调查波多黎各成年(18岁及以上)西班牙裔人群中接受手术治疗的垂体腺瘤的手术发病率(每10万人)。对2017年至2022年期间在波多黎各医疗中心接受手术的所有新诊断为垂体腺瘤的患者进行了仔细审查。纳入标准要求垂体腺瘤的组织病理学诊断。先前接受过手术的病例和非西班牙裔患者被排除在研究之外。收集了患者的特征,以及手术治疗类型、肿瘤大小和分泌状态。
分析包括143例接受垂体腺瘤手术的患者。其中,75例(52%)为男性,68例(48%)为女性。患者的中位年龄为56岁(范围:18 - 85岁)。成年西班牙裔垂体腺瘤患者的平均年手术发病率为0.73例/10万人。约79%的患者患有无功能性垂体腺瘤。约94%的患者接受了经蝶窦手术。
在波多黎各,接受手术治疗的垂体腺瘤不存在性别优势。2017年至2022年期间,成年垂体腺瘤的手术发病率保持稳定。